Cns Pharmaceuticals Stock Price on March 20, 2024
| CNSP Stock | USD 0.11 0.01 10.00% |
Below is the normalized historical share price chart for Cns Pharmaceuticals extending back to November 08, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cns Pharmaceuticals stands at 0.11, as last reported on the 25th of December, with the highest price reaching 0.11 and the lowest price hitting 0.10 during the day.
If you're considering investing in Cns Stock, it is important to understand the factors that can impact its price. Cns Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0187, which signifies that the company had a -0.0187% return per unit of risk over the last 3 months. Cns Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cns Pharmaceuticals' Mean Deviation of 4.37, risk adjusted performance of (0.01), and Standard Deviation of 7.01 to double-check the risk estimate we provide.
At this time, Cns Pharmaceuticals' Common Stock is relatively stable compared to the past year. As of 12/25/2024, Capital Stock is likely to grow to about 11.8 K, while Common Stock Shares Outstanding is likely to drop slightly above 71.6 K. . As of 12/25/2024, Price Earnings Ratio is likely to drop to -0.27. In addition to that, Price Book Value Ratio is likely to drop to -1.13. Cns Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of November 2019 | 200 Day MA 6.3627 | 50 Day MA 0.1331 | Beta 1.049 |
Cns |
Sharpe Ratio = -0.0187
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNSP |
Estimated Market Risk
| 7.18 actual daily | 63 63% of assets are less volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cns Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cns Pharmaceuticals by adding Cns Pharmaceuticals to a well-diversified portfolio.
Price Book 1.8692 | Book Value (2.98) | Enterprise Value -675.9 K | Enterprise Value Ebitda 0.4007 | Shares Float 31.4 M |
Cns Pharmaceuticals Main Headline on 20th of March 2024
The United States has received mixed signals from Niger following the ruling juntas weekend announcement that it had revoked an accord allowing U.S. troops to operate in the West African country, the top U.S. general said on Tuesday. Air Force General C.Q. Brown, chairman of the Joint Chiefs of Staff, did not elaborate on those mixed signals but his comments appeared to suggest at least some support from within Nigers ruling junta for a continued U.S. military presence.
Cns Pharmaceuticals Valuation on March 20, 2024
It is possible to determine the worth of Cns Pharmaceuticals on a given historical date. On March 20, 2024 Cns was worth 17.75 at the beginning of the trading date compared to the closed value of 18.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cns Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Cns Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cns Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cns Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 18.75 | 19.00 | 17.00 | 17.30 | 2,924 | |
03/20/2024 | 17.75 | 22.00 | 17.50 | 18.10 | 4,564 |
| 18.50 | 19.40 | 17.55 | 17.55 | 1,344 |
| Backtest Cns Pharmaceuticals | | | Cns Pharmaceuticals History | | | Cns Pharmaceuticals Valuation | Previous | Next |
Cns Pharmaceuticals Trading Date Momentum on March 20, 2024
| On March 21 2024 Cns Pharmaceuticals was traded for 17.55 at the closing time. The top price for the day was 19.40 and the lowest listed price was 17.55 . The trading volume for the day was 1.3 K. The trading history from March 21, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.04% . The overall trading delta against the current closing price is 6.63% . |
Cns Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Cns Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cns Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cns financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cns Pharmaceuticals Stock history
Cns Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cns is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cns Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cns Pharmaceuticals stock prices may prove useful in developing a viable investing in Cns Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 75.3 K | 71.6 K | |
| Net Loss | -12.6 M | -12 M |
Cns Pharmaceuticals Stock Technical Analysis
Cns Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cns Pharmaceuticals Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
Cns Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cns Pharmaceuticals December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Cns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cns Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cns Pharmaceuticals stock market strength indicators, traders can identify Cns Pharmaceuticals entry and exit signals to maximize returns
Cns Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cns Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cns Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cns to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.19) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cns Stock Analysis
When running Cns Pharmaceuticals' price analysis, check to measure Cns Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cns Pharmaceuticals is operating at the current time. Most of Cns Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cns Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cns Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cns Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.